Kitea Health, a New Zealand start-up specializing in implantable brain pressure sensors, has secured $6 million in funding to advance its clinical trials and expand into global markets.

Target Information

Kitea Health, a New Zealand-based start-up, is renowned for developing the world’s first implantable long-term brain pressure sensor. The company aims to revolutionize the management of chronic conditions, particularly hydrocephalus, which predominantly affects children and the elderly. With the device approximately the size of a few grains of rice, Kitea Health's technology allows for the remote monitoring of cerebrospinal fluid pressure, enabling healthcare professionals and patients to receive real-time data for better management of the condition.

Founded as a spinout from the University of Auckland's Bioengineering Institute, Kitea Health is focused on innovating healthcare solutions to address critical challenges in chronic condition management. The firm intends to leverage the recent funding to scale its clinical trial program and expedite its global market entry, particularly in the United States by the end of 2025.

Industry Overview in New Zealand

The deep-tech sector in New Zealand has been burgeoning, characterized by its innovative approaches and significant investment potential. With a strong emphasis on research and development, New Zealand is positioning